Wealth Enhancement Advisory Services LLC Raises Stake in Bath & Body Works, Inc. $BBWI

Key Points

• Wealth Enhancement Advisory Services LLC has increased its stake in Bath & Body Works by 71.0%, now owning 71,329 shares valued at approximately $2.36 million.
• Institutional investors collectively hold 95.14% of Bath & Body Works' stock, indicating strong institutional interest in the company.
• Bath & Body Works recently announced a quarterly dividend of $0.20 per share, reflecting an annualized yield of 3.0%.

Wealth Enhancement Advisory Services LLC increased its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 71.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 71,329 shares of the company's stock after buying an additional 29,618 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Bath & Body Works were worth $2,364,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in BBWI. T. Rowe Price Investment Management Inc. grew its holdings in shares of Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock valued at $334,029,000 after purchasing an additional 781,681 shares during the last quarter. Victory Capital Management Inc. raised its position in shares of Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after buying an additional 6,752,274 shares in the last quarter. Alliancebernstein L.P. lifted its stake in shares of Bath & Body Works by 4.7% in the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock worth $164,397,000 after acquiring an additional 243,611 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company's stock valued at $121,073,000 after acquiring an additional 2,907,506 shares in the last quarter. Finally, GMT Capital Corp raised its holdings in Bath & Body Works by 7.3% during the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company's stock worth $113,327,000 after purchasing an additional 255,600 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Wall Street Analysts Forecast Growth

BBWI has been the subject of a number of research reports. Telsey Advisory Group reaffirmed an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a research note on Thursday, August 28th. JPMorgan Chase & Co. raised their target price on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Citigroup dropped their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. Wall Street Zen lowered shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Barclays lifted their target price on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a report on Friday, August 29th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of "Moderate Buy" and a consensus target price of $39.69.

Bath & Body Works Stock Performance

Shares of BBWI opened at $26.60 on Friday. Bath & Body Works, Inc. has a 52-week low of $24.93 and a 52-week high of $41.87. The company has a market cap of $5.49 billion, a price-to-earnings ratio of 7.89, a PEG ratio of 0.91 and a beta of 1.49. The stock has a fifty day moving average price of $29.07 and a two-hundred day moving average price of $29.60.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. The business had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works's revenue for the quarter was down .8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were given a $0.20 dividend. The ex-dividend date was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.0%. Bath & Body Works's dividend payout ratio (DPR) is currently 23.74%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.